John Overdeck’s NRC Health Common Stock NRC Stock Holding History

John Overdeck’s Portfolio NRC Stock Details NRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.36M	Sell	62,938 -872	-1%	-$16.2K	﹤0.01%	3367
2026 Q1	$1.08M	Sell	63,810 -27,259	-30%	-$463K	﹤0.01%	3207
2025 Q4	$1.71M	Buy	91,069 +30,157	+50%	+$455K	﹤0.01%	2549
2025 Q3	$778K	Buy	60,912 +30,296	+99%	+$454K	﹤0.01%	2740
2025 Q2	$514K	Buy	30,616 +8,351	+38%	+$113K	﹤0.01%	2576
2025 Q1	$285K	Sell	22,265 -19,426	-47%	-$312K	﹤0.01%	2735
2024 Q4	$735K	Buy	41,691 +9,399	+29%	+$178K	﹤0.01%	2348
2024 Q3	$738K	Sell	32,292 -32,373	-50%	-$731K	﹤0.01%	2280
2024 Q2	$1.48M	Buy	64,665 +53,979	+505%	+$1.66M	﹤0.01%	1756
2024 Q1	$423K	Sell	10,686 -35,796	-77%	-$1.42M	﹤0.01%	2409
2023 Q4	$1.84M	Buy	+46,482	New	+$1.95M	﹤0.01%	1640
2013 Q3	–	Sell	-15,594	Closed	-$280K	–	2021
2013 Q2	$280K	Buy	+15,594	New	+$249K	﹤0.01%	1663

Other funds holding NRC

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

WIC

Willis Investment Counsel Gainesville, Georgia $2.1B AUM 24.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return

FMII

Farmers & Merchants Investments Inc Lincoln, Nebraska $4.13B AUM 32.58% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

John Overdeck's NRC Position: Q2 2026 in Review

John Overdeck reduced its NRC Health Common Stock (NRC) stake by 1.4% in Q2 2026, selling an estimated $16.2K and leaving 62,938 shares worth $1.36M. The position accounts for ﹤0.01% of the portfolio, ranked #3367.

John Overdeck first reported a position in NRC in Q2 2013 and has held it in 12 quarters since. The position peaked at $1.84M in Q4 2023. 123 funds tracked by Wall St. Rank hold NRC as of Q2 2026.

John Overdeck held 62,938 shares of NRC Health Common Stock worth $1.36M as of Q2 2026.
John Overdeck sold 872 NRC Health Common Stock shares in Q2 2026, an estimated $16.2K.
NRC Health Common Stock made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #3367 holding.
John Overdeck first reported a position in NRC Health Common Stock in Q2 2013 and has held it in 12 quarters since.
John Overdeck's NRC Health Common Stock position peaked at $1.84M in Q4 2023.
123 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.